| 2/21/2025 | BK | Eversana prices $950 million term loan at SOFR plus 450 bps at 99.5; allocations made
|
| 2/19/2025 | BK | Moody's gives Eversana loans B2
|
| 2/13/2025 | BK | S&P gives B- to LSCS loans
|
| 2/11/2025 | BK | Market Commentary: APi Group breaks; WHP Global, Mediaocean updated; Apex Group, Minimax, Novelis set talk
|
| 2/11/2025 | BK | Eversana to launch $1.06 billion credit facilities on Wednesday
|
| 11/23/2021 | BK | Market Commentary: Dotdash, Eversana, Snap One, Flynn, Consilio, Garda World, Solmax, Kestra, Meridian break
|
| 11/23/2021 | BK | Eversana increases first-lien term loan amount, updates pricing
|
| 11/9/2021 | BK | Market Commentary: Acrisure, Howden Group, Monotype, PCI Pharma break; Parts Authority, Apex revise deals
|
| 11/9/2021 | BK | S&P rates LSCS loans B-, CCC
|
| 11/9/2021 | BK | Moody’s gives Eversana loans B2, Caa2
|
| 11/9/2021 | BK | Eversana sets first- and second-lien term loan price talk with launch
|
| 11/8/2021 | BK | Market Commentary: FR Refuel, Angus, Summit Behavioral break; PCI changes emerge; Vantage Elevator accelerated
|
| 11/8/2021 | BK | Eversana to launch $1.07 billion of credit facilities on Tuesday
|
| 6/30/2020 | BK | S&P revises Eversana view to negative
|
| 4/5/2019 | BK | S&P lowers LSCS, loans
|
| 3/12/2018 | BK | Moody’s gives LSCS loans B2, Caa2
|
| 3/6/2018 | BK | S&P rates LSCS facilities B, CCC+
|
| 2/20/2018 | BK | S&P rates LSCS B, facilities B, CCC+
|
| 2/20/2018 | BK | Moody’s rates LSCS B3; facilities B2, Caa2
|
